We provide comprehensive support ranging from specialized tissue dissociation and synchronized cell capture to high-end bioinformatic interpretation, ensuring a seamless transition from raw samples to actionable biological targets.
Creative Biolabs provides an exhaustive transcriptomic deep-dive into the regenerative drivers of cancer. We provide researchers with high-resolution cellular maps, metabolic flux predictions, and regulatory network reconstructions (regulons). By partnering with us, clients gain a clear understanding of the molecular mechanisms governing tumor heterogeneity, enabling the identification of high-value targets and the assessment of drug efficacy at the single-cell level. Expect to gain a definitive biological narrative of your model's resistance profile and a prioritized list of targets for downstream validation.
Cancer Stem Cells (CSCs) are the architects of tumor growth and metastatic potential in research models. Recent scientific literature emphasizes that CSCs utilize signaling entropy, metabolic plasticity, and niche-reprogramming to evade experimental compounds. These studies conclude that bulk sequencing masks the critical quiescent states and hybrid phenotypes essential for survival. Single-cell RNA-seq provides the necessary resolution to decode these hierarchical structures, allowing for the identification of the master transcription factors that govern malignancy at its source.
Fig.1 Landscape of tumor cell subpopulations in the HCC microenvironment. 1
We provide comprehensive support ranging from specialized tissue dissociation and synchronized cell capture to high-end bioinformatic interpretation, ensuring a seamless transition from raw samples to actionable biological targets.
Our experts tailor every protocol to accommodate diverse research samples, including primary tumor-derived cells and complex organoids, ensuring optimal data quality specifically for your unique model.
Utilizing advanced microfluidics, we analyze over 100,000 individual cells per project. This massive scale ensures the statistical capture and characterization of even the rarest cancer stem clusters.
We utilize proprietary cold-dissociation methods and specialized stabilization reagents throughout the workflow to prevent artificial stress signatures and preserve the delicate, native transcriptomic state of stemness.
Creative Biolabs combines decades of molecular oncology research with cutting-edge transcriptomic technology, providing a sophisticated analytical framework that standard sequencing providers simply cannot match in precision.
We utilize full-length transcript coverage to pinpoint rare isoform switches. This level of detail is essential for identifying the specific structural variants that define true stemness.
Our proprietary algorithms analyze signaling entropy and metabolic plasticity. This ensures that even the most elusive, quiescent subpopulations are accurately captured, characterized, and quantified for your study.
We deliver more than raw data; we provide comprehensive biological narratives. Our insights help you disrupt tumor regenerative capacity by identifying high-value targets within research environments.
To experience tailored precision provided by Creative Biolabs, get a quote today.
While we can work with smaller inputs, we recommend providing a sufficient cell count to ensure adequate representation of rare subpopulations in the research sample.
We utilize a multi-dimensional approach, including surface marker scoring, signaling entropy rate, and the expression of core regulons identified via active regulon analysis.
We utilize flow cytometry to identify and validate unique proteomic signatures on stem-like subpopulations, facilitating high-precision sorting and targeted research validation.
Learn More →We quantify inhibitory and stimulatory checkpoint expression on stem-like clusters, identifying mechanisms of immune evasion to assist in the development of next-generation immunotherapeutic research models.
Learn More →Creative Biolabs provides the high-resolution data and biological expertise required to unmask the cells responsible for cancer progression in research models. By targeting the "engine" of the tumor, we help you accelerate drug discovery and refine development strategies. For detailed project discussions or to receive a technical proposal tailored to your research model, please reach out to our specialist team.
Reference